Data from Brainomix’s collaboration with AstraZeneca shows its AI-powered e-Lung better identifies lung fibrosis patients at risk of decline
Brainomix, the AI-powered MedTech company, has announced the publication of a new study in the prestigious peer-reviewed journal American Journal of Respiratory and Critical Care Medicine (AJRCCM), resulting from a research collaboration AstraZeneca, a...